Web-Based Advance Care Planning for Patients With Advanced Cancer (NCT07712237) | Clinical Trial Compass
CompletedNot Applicable
Web-Based Advance Care Planning for Patients With Advanced Cancer
Taiwan110 participantsStarted 2023-10-16
Plain-language summary
The goal of this clinical trial is to determine whether a web-based advance care planning (ACP) intervention can reduce preferences for aggressive life-sustaining treatments among patients with advanced cancer.
The main questions it aims to answer are:
* Does a web-based ACP intervention reduce preferences for aggressive life-sustaining treatments among patients with advanced cancer?
* Does a web-based ACP intervention support informed medical decision-making regarding future care?
Researchers will compare a web-based ACP intervention plus a Patient Right to Autonomy Act leaflet with a Patient Right to Autonomy Act leaflet alone to determine whether the web-based ACP intervention is more effective in reducing preferences for aggressive life-sustaining treatments.
Participants will:
* Be randomly assigned to either an intervention group or a control group
* Receive either a web-based ACP educational program plus a Patient Right to Autonomy Act leaflet, or a Patient Right to Autonomy Act leaflet alone
* Complete questionnaires at baseline, immediately after the intervention, and one week after the intervention
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosed with advanced cancer (stage III or IV)
* Aged 18 years or older
* Able to communicate fluently in Mandarin Chinese or Taiwanese
* Able and willing to provide informed consent
* No cognitive impairment
* Have access to Internet-connected electronic devices at home
* Have not previously received advance care planning (ACP) consultation
* Have not completed an advance directive (AD)
Exclusion Criteria:
* No access to Internet-connected electronic devices at home
* Unable to operate Internet-based electronic devices
* Previous participation in ACP consultation or completion of an AD
* Cognitive impairment
* Severe physical or psychological symptoms that would interfere with participation in the study
* Concurrent participation in another intervention study
* Refusal to participate
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Preference for Aggressive Life-Sustaining Treatments